AGENTS AND METHOD FOR DIAGNOSING LYME DISEASE AND BORRELIOSIS VACCINE

摘要

Die Erfindung betrifft Mittel zur Diagnose und/oder Therapie von Lyme Borreliose enthaltend die Antigene Glyceraldehyd-3-phosphat-Dehydrogenase (GAPDH), Oligopeptid-Permease, Oligopeptid ABC transporter periplasmic BP(oppA-2)(Bb), Glycosyl transfase IgtD homolog, heat shock Protein 90, VLSE fragment, (U76406) putative v1s rec. casette V1s6 Borrelia burgdorferii, Flagellin Protein Borrelia garinii, (AE001578) conserved hypothetical protein cp32-6 Borrelia burgdorferii, membrane assoc. protein p66 precursor Borrelia burgdoferii, Oligopeptid ABC transporter periplasmic BP (oppA-4)(Bc), Fructose-biphosphate aldose (fba) Borrelia burgdorferii, DNAK Protein Heat Shock Protein 70 Borrelia burgdorferii, orfE Borrelia burgdorferii, Outer surface protein B precursor Borrelia burgdorferii, L-lactate dehydrogenase (ldh), P83/100 gene Borrelia burgdorferii, Enolase 2phosphoglycerat Borrelia burgdorferii, Flagellin Protein Borrelia garinii, hypothetical protein BBE28 Borrelia burgdorferii, DNA direct. RNA polymase (rpoA) homolog, P66 protein (fragment), Flagellin (fragment), DNA direct. RNA polymase, integral outer membran protein p66, pyruvate kinase (pyk) homolog; Phosphoglycerat kinase (pgk) und/oder BBU28760 NID und/oder deren Fragmente und/oder für die Antigene und/oder Fragmente codierenden Nucleinsäuresequenzen.